Its a moment every serious researcher faces
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
Cytoprotective properties: Research has demonstrated that BPC may serve as a useful cytoprotective peptide therapy in heart disturbances, myocardial infarction, and heart failure (6)
Residents of other countries must refer to respective laws
Piglets, dogs: 1-2 mL per head
PLoS ONE 10 , e0125369 (2015)
